Related Experiment Video
Updated: Dec 24, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis
Ilaha Isali1, Mohammed Adel Ali Al-Sadawi1, Arshna Qureshi2
1Department of Urology, Case Western Reserve University, Cleveland, OH.
Abstract:
Growth factors play active role in cells proliferation, embryonic development regulation and cellular differentiation. Altered level growth factors promote malignant transformation of normal cells. There has been significant progress made in form of drugs, inhibitors and monoclonal antibodies against altered growth factor to treat the malignant form of cancer. Moreover, these altered growth factors in prostate cancer increases steroidal hormone levels, which promotes progression. Though this review we are highlighting the majorly involved growth factors in prostate carcinogenesis, this will enable to better design the therapeutic strategies to inhibit prostate cancer progression.
Insights
Growth factors are key in cell growth and development. This review highlights their role in prostate cancer, aiding the development of targeted therapies for better treatment outcomes.
Area of Science:
- Oncology and Molecular Biology
- Cellular signaling pathways
- Cancer research
Background:
- Growth factors regulate essential cellular processes like proliferation, differentiation, and development.
- Aberrant growth factor signaling is implicated in the malignant transformation of normal cells.
- Altered growth factors contribute to prostate cancer progression by increasing steroidal hormone levels.
Purpose of the Study:
- To review the major growth factors involved in prostate carcinogenesis.
- To provide insights for designing targeted therapeutic strategies against prostate cancer progression.
Main Methods:
- Literature review focusing on growth factors in prostate cancer.
- Analysis of the role of specific growth factors in prostate carcinogenesis.
- Synthesis of current therapeutic approaches targeting growth factors.
Main Results:
- Identification of key growth factors driving prostate cancer development and progression.
- Understanding the link between altered growth factors and increased steroidal hormone levels in prostate cancer.
- Overview of existing and emerging therapeutic strategies, including drugs, inhibitors, and monoclonal antibodies.
Conclusions:
- Growth factors are critical targets for prostate cancer therapy.
- Targeting specific growth factors can inhibit prostate cancer progression.
- Further research into growth factor signaling pathways will enhance therapeutic design.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

